Dodge & Cox’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.5M Sell
41,258
-754
-2% -$770K 0.03% 113
2026
Q1
$38.6M Sell
42,012
-480
-1% -$487K 0.02% 113
2025
Q4
$45.7M Sell
42,492
-892
-2% -$853K 0.02% 111
2025
Q3
$33.1M Sell
43,384
-1,573
-3% -$1.17M 0.02% 113
2025
Q2
$35M Sell
44,957
-129
-0.3% -$100K 0.02% 113
2025
Q1
$37.2M Buy
45,086
+289
+0.6% +$240K 0.02% 106
2024
Q4
$34.6M Sell
44,797
-293
-0.6% -$243K 0.02% 108
2024
Q3
$39.9M Sell
45,090
-888
-2% -$798K 0.02% 106
2024
Q2
$41.6M Sell
45,978
-947
-2% -$758K 0.03% 103
2024
Q1
$36.5M Sell
46,925
-7,104
-13% -$5.06M 0.02% 105
2023
Q4
$31.5M Sell
54,029
-961
-2% -$561K 0.02% 104
2023
Q3
$29.5M Sell
54,990
-4,655
-8% -$2.4M 0.02% 104
2023
Q2
$28M Sell
59,645
-1,917
-3% -$804K 0.02% 102
2023
Q1
$21.1M Sell
61,562
-2,125
-3% -$717K 0.01% 104
2022
Q4
$23.3M Sell
63,687
-6,007
-9% -$2.13M 0.02% 102
2022
Q3
$22.5M Sell
69,694
-1,487
-2% -$471K 0.02% 102
2022
Q2
$23.1M Sell
71,181
-1,532
-2% -$460K 0.02% 102
2022
Q1
$20.8M Sell
72,713
-8,395
-10% -$2.16M 0.01% 102
2021
Q4
$22.4M Sell
81,108
-3,600
-4% -$913K 0.01% 98
2021
Q3
$19.6M Sell
84,708
-1,097
-1% -$271K 0.01% 94
2021
Q2
$19.7M Sell
85,805
-6,561
-7% -$1.32M 0.01% 92
2021
Q1
$17.3M Sell
92,366
-14,147
-13% -$2.77M 0.01% 94
2020
Q4
$18M Sell
106,513
-18,880
-15% -$2.82M 0.01% 95
2020
Q3
$18.6M Sell
125,393
-45,229
-27% -$7M 0.02% 92
2020
Q2
$28M Sell
170,622
-120,885
-41% -$18.6M 0.03% 88
2020
Q1
$40.4M Sell
291,507
-7,796,551
-96% -$1.07B 0.04% 82
2019
Q4
$1.06B Sell
8,088,058
-730,995
-8% -$84.7M 0.81% 44
2019
Q3
$986M Sell
8,819,053
-42,104
-0.5% -$4.69M 0.81% 44
2019
Q2
$982M Sell
8,861,157
-5,818,238
-40% -$685M 0.79% 46
2019
Q1
$1.9B Sell
14,679,395
-821,500
-5% -$99.9M 1.56% 30
2018
Q4
$1.79B Sell
15,500,895
-7,192,076
-32% -$803M 1.64% 26
2018
Q3
$2.44B Sell
22,692,971
-4,327,500
-16% -$433M 1.86% 19
2018
Q2
$2.31B Buy
27,020,471
+5,178,354
+24% +$425M 1.84% 22
2018
Q1
$1.69B Buy
21,842,117
+1,660,830
+8% +$134M 1.36% 32
2017
Q4
$1.7B Buy
20,181,287
+161,210
+0.8% +$13.7M 1.32% 32
2017
Q3
$1.71B Buy
20,020,077
+14,028,125
+234% +$1.15B 1.38% 31
2017
Q2
$493M Buy
5,991,952
+5,964,955
+22,095% +$487M 0.42% 65
2017
Q1
$2.27M Sell
26,997
-1,600
-6% -$128K ﹤0.01% 120
2016
Q4
$2.1M Sell
28,597
-735
-3% -$54.7K ﹤0.01% 121
2016
Q3
$2.35M Hold
29,332
﹤0.01% 115
2016
Q2
$2.31M Sell
29,332
-1,860
-6% -$140K ﹤0.01% 114
2016
Q1
$2.25M Sell
31,192
-400
-1% -$30.3K ﹤0.01% 116
2015
Q4
$2.66M Sell
31,592
-42
-0.1% -$3.48K ﹤0.01% 114
2015
Q3
$2.65M Sell
31,634
-1,000
-3% -$84.4K ﹤0.01% 110
2015
Q2
$2.73M Sell
32,634
-3,600
-10% -$274K ﹤0.01% 107
2015
Q1
$2.63M Sell
36,234
-2,770
-7% -$197K ﹤0.01% 109
2014
Q4
$2.69M Sell
39,004
-3,460
-8% -$234K ﹤0.01% 111
2014
Q3
$2.75M Buy
42,464
+7,190
+20% +$455K ﹤0.01% 107
2014
Q2
$2.19M Sell
35,274
-486
-1% -$29K ﹤0.01% 113
2014
Q1
$2.1M Hold
35,760
﹤0.01% 112
2013
Q4
$1.82M Hold
35,760
﹤0.01% 115
2013
Q3
$1.8M Sell
35,760
-200
-0.6% -$10.5K ﹤0.01% 115
2013
Q2
$1.77M Buy
+35,960
New +$1.96M ﹤0.01% 118

Other funds holding LLY

Dodge & Cox's LLY Position: Q2 2026 in Review

Dodge & Cox reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $770K and leaving 41,258 shares worth $49.5M. The position accounts for 0.03% of the portfolio, ranked #113.

Dodge & Cox first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.44B in Q3 2018. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dodge & Cox held 41,258 shares of Eli Lilly worth $49.5M as of Q2 2026.
  • Dodge & Cox sold 754 Eli Lilly shares in Q2 2026, an estimated $770K.
  • Eli Lilly made up 0.03% of Dodge & Cox's portfolio in Q2 2026, its #113 holding.
  • Dodge & Cox first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Dodge & Cox's Eli Lilly position peaked at $2.44B in Q3 2018.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.